The plasma levels of adiponectin are low in obesity, type 2 diabetes mellitus (DM), insulin resistance, dyslipidemia, coronary artery disease (CAD), and peripheral arterial disease (PAD) [14–16]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.